ARM’s programs bring together the people and perspectives shaping the future of cell and gene therapy. From engaging patient voices and educating investors to advancing manufacturing, policy, and ethics, we work across the field to turn big challenges into shared progress.
While ARM’s core work focuses on network building, advocacy, and scientific outreach, we also lead special initiatives that respond to pressing field-wide needs. From manufacturing to workforce and data, these programs help the sector prepare for what’s ahead.
Elevating patient and caregiver perspectives across ARM’s work through storytelling, advocacy, ethics forums, and engagement initiatives.
Helping the investor community understand the CGT pipeline, progress on delivery, and why it’s time to believe in the field’s maturity.
Convening the field to navigate pricing, ultra-rare diseases, global access, industrialization, and the use of emerging technology.
ARM’s programs bring together the people and perspectives shaping the future of cell and gene therapy. From engaging patient voices and working with investors to advancing manufacturing, policy, and ethics, we work across the field to turn big challenges into shared progress.
ARM brings together patients, investors, scientists, academics, policymakers, and regulators to advance CGT responsibly and sustainably.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
